Riskpilot← Back to searchSign inGet full accessSweBol Biotech AB
ABActiveOrg 5590236187LundNon-specialised retail sale of predominately food, beverages or tobacco · NACE 4711Est. 20150 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
SEK -1K
+100% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | — |
| Net profit | SEK -1K | +100% |
| Total assets | SEK 2K | -33% |
| Equity | SEK 2K | -33% |
| Employees | 0 | — |
Legal name
SweBol Biotech AB
Org number
5590236187
Legal form
Aktiebolag
NACE code
4711 · Non-specialised retail sale of predominately food, beverages or tobacco
Founded
21 augusti 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Böök, Carl Olof Öste, Erik Rickard
Company purpose
Föremålet för bolagets verksamhet är att bedriva livsmedels- teknisk forskning, utveckling och konsulttjänster samt handel inom närliggande områden i livsmedelsbranschen och därmed förenlig verksamhet.
Address
Lund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 26 | 16 | 20 | 10 | 10 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — |
| EBITDA | −19 | −3 | 7 | 4 | 13 | −18 | 8 | — | −1 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −267 | −0 |
| EBIT | −19 | −3 | 7 | 4 | 13 | −18 | 8 | −267 | −1 |
| Net financials | — | — | — | — | — | — | — | −748 | — |
| Profit before tax | −19 | −3 | 7 | 4 | 13 | −18 | 8 | −641 | −1 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −19 | −3 | 7 | 4 | 13 | −18 | 8 | −641 | −1 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 399 | 447 | 643 | 645 | 658 | 640 | 649 | 3 | 2 |
| Equity | 31 | 28 | 35 | 38 | 51 | 33 | 41 | 3 | 2 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 368 | 419 | 609 | 607 | 607 | 607 | 609 | 0 | 0 |
| Total debt | 368 | 419 | 609 | 607 | 607 | 607 | 609 | — | — |
EBITDA margin
-100000.0%
This company
15.8%
Market median
-633011% vs market
20162024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20162024
Return on equity
-50.0%
This company
18.4%
Market median
-372% vs market
20162024
Net profit margin
-100000.0%
This company
8.1%
Market median
-1234668% vs market
20162024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20162024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-08-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CO Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SweBol Biotech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Olof Böök | Chief Executive Officer | 0 companies |
| Per Lennart Olof Olsson | Board of Directors | 0 companies |
| Erik Rickard Öste | Chairman | 0 companies |